Cargando…
Drug safety : progress and controversies : proceedings of the IVth International Congress of Pharmaceutical Physicians = S�ecurit�e et m�edicament : progr�es et controverses : comptes rendus du IVe congr�es international des m�edecins de l'industrie pharmaceutique /
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , , |
| Formato: | Electrónico Congresos, conferencias eBook |
| Idioma: | Inglés Francés |
| Publicado: |
Paris ; New York :
Pergamon Press,
[1982]
|
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | SCIDIR_ocn884457497 | ||
| 003 | OCoLC | ||
| 005 | 20231120111704.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 140723s1982 fr a o 100 0 eng d | ||
| 040 | |a OPELS |b eng |e rda |e pn |c OPELS |d N$T |d OCLCF |d EBLCP |d OCLCO |d OCLCQ |d OCLCO |d DEBSZ |d OCLCO |d OCL |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d YDXCP |d OCL |d OCLCO |d UAB |d MERUC |d STF |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCO |d COM |d OCLCO |d OCLCQ |d OCLCO | ||
| 019 | |a 896795117 | ||
| 020 | |a 9781483140377 |q (electronic bk.) | ||
| 020 | |a 1483140377 |q (electronic bk.) | ||
| 020 | |z 9780080270746 | ||
| 035 | |a (OCoLC)884457497 |z (OCoLC)896795117 | ||
| 041 | 0 | |a eng |a fre | |
| 050 | 4 | |a RS189 |b .I523 1981eb | |
| 060 | 4 | |a QV771 In82p 1981 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.1 |2 22 |
| 111 | 2 | |a International Congress of Pharmaceutical Physicians |n (4th : |d 1981 : |c Paris, France) | |
| 245 | 1 | 0 | |a Drug safety : |b progress and controversies : proceedings of the IVth International Congress of Pharmaceutical Physicians = S�ecurit�e et m�edicament : progr�es et controverses : comptes rendus du IVe congr�es international des m�edecins de l'industrie pharmaceutique / |c editors, Michel Auriche, John Burke, Jacques Duchier. |
| 246 | 3 | |a S�ecurite et m�edicament | |
| 264 | 1 | |a Paris ; |a New York : |b Pergamon Press, |c [1982] | |
| 264 | 4 | |c �1982 | |
| 300 | |a 1 online resource (xviii, 308 pages) : |b illustrations | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 500 | |a "Paris, 27/30 April 1981." | ||
| 500 | |a "The 4th International Meeting of Pharmaceutical Physicians."--Page vii | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Front Cover; Copyright Page; Drug Safety: Progress and Controversies; Table of Contents; PREFACE; ALLOCUTION DE BIENVENUE; Introduction; PART I: DRUG SAFETY: A MULTIFACETED PROBLEM DIVERSITE DES PROBLEMES POSES PAR L'EVALUATION DE LA SECURITE ENMATIERE DE MEDICAAIENTS; Chapter 1. The Scientific Basis of Drug Safety Regulations; HOW CAN DRUG SAFETY BE REGULATED?; DO DRUG SAFETY REQUIREMENTS IMPEDE DRUG INNOVATION?; WHAT IS THE SIGNIFICANCE OF THE BENEFIT-TO-RISR RATIO?; WHERE ARE THE LIMITS OF SAFETY REGULATIONS?; CAN CLINICAL TRIALS BE EXPEDITED WITHOUT NEGLECTING DRUG SAFETY? | |
| 505 | 8 | |a HOW CAN THE SCIENTIFIC BASIS OF DRUG SAFETY BE IMPROVED?REFERENCES; Chapter 2. The Effects of Drug Regulation on Iatrogenic Disease; Abstract; A FOLLOW-UP STUDY OF REJECTIONS; A RETROSPECTIVE STUDY OF RESTRICTIVE DECISIONS; MAJOR IATROGENIC ACCIDENTS IN RETROSPECT; EFFICIENCY OF REGULATORY ACTIVITY ON SAFETY MATTERS; OTHER TECHNIQUES; AN INVALID TECHNIQUE; CONCLUSIONS; REFERENCES; Chapter 3. Deregulation of Drug Development: If Effective, Can it be Safe?; Abstract; THE EARLY STAGES : LESS-STHINGENT CONTROL; SEQUENTIAL SUBMISSION AND REVIEW; REALISTIC STANDARDS OF EVIDENCE FOR EFFICACY. | |
| 505 | 8 | |a ACCEPTANCE OF FOREIGN AND IRREGULAR DATAIMPROVED ADMINISTRATIVE AND MANAGEMENT TECHNIQUES; POSTMARKETING ISSUES; CONCLUSIONS; REFERENCES; Chapter 4. Les grainds m�edicaLinents d'hier auraient-ils franchi avec succes le bairrage de la r�eglementation pr�eclinique actuelle?; Resume; LES COMMISSIONS D'AGREMENT; LE PRIX ET LA DUR�EE DES ESSAIS PR�ECLINIQUES; LES LABORATOIRES DE RECHERCHE PHARMACEUTIQUE; QUELQUES DOSSIERS DE GRANDS MEDICAMENTS ANCIENS; CONCLUSIONS; REFERENCES; Chapter 5. The Intemationad Transfer of Information Regarding Drug Saifety : Benefits, Difficulties and Solutions; Abstract. | |
| 505 | 8 | |a Chapter 6. Ethicad Considerations in Drug Saifety EvaduationAbstract; CONFLICT OF INTEREST IN RESEARCH; ETHICAL ISSUES IN CLINICAL DRUG TRIALS; THE MARKETING AND USE OF DRUGS; DRUGS IN T H E THIRD WORLD; THE CARE AND FEEDING OF PHARAiACEUTICAL PHYSICIANS; REFERENCES; Chapter 7. A Compairisoii of International Guidelines for the Clinicad Evaduation of Psychotropic Drugs The Price of Safety; Abstract; Chapter 8. USA et FDA Versus CEE et CSP Une etude comparative ouverte des medicaments anti-aingoreux; Resume. | |
| 505 | 8 | |a PART II:POST MARKETING SAFETY ASSESSMENT INTERET ET LIMITES DES METHODES D'EVALUATION CLINIQUE DES EFFETS INDESIRABLES DES MEDICAMENTS APRES MISE SUR LE MARCHE: PRESENT METHODSChapter 9. Spontaneous Notification; Abstract; DEFICIENCIES OF PRE-MARKETING TESTS; PRESCRIBING CONDITIONS; ADR REGISTERS IN PMS; ADVANTAGES AND DISADVANTAGES; SPONTANEOUS REPORTING AND IDENTIFICATION OF A NEW HAZARD; RELATIVE RISKS OF VARIOUS DRUGS; ADR'S AND IN-DEPTH STUDIES; WHEN AND WHAT TO REPORT; FEEDBACK OF INFORMATION; CONCLUDING REMARKS; REFERENCES. | |
| 650 | 0 | |a Drugs |v Congresses. | |
| 650 | 0 | |a Drugs |x Side effects |v Congresses. | |
| 650 | 2 | |a Pharmaceutical Preparations |x standards |0 (DNLM)D004364Q000592 | |
| 650 | 2 | |a Drug Evaluation |0 (DNLM)D004341 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0002990 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 6 | |a M�edicaments |0 (CaQQLa)201-0002241 |x Effets secondaires |0 (CaQQLa)201-0002241 |v Congr�es. |0 (CaQQLa)201-0378219 | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |2 fast |0 (OCoLC)fst00898761 | |
| 650 | 7 | |a Drugs |x Side effects |2 fast |0 (OCoLC)fst00898912 | |
| 655 | 2 | |a Congress |0 (DNLM)D016423 | |
| 655 | 7 | |a proceedings (reports) |2 aat |0 (CStmoGRI)aatgf300027316 | |
| 655 | 7 | |a Conference papers and proceedings |2 fast |0 (OCoLC)fst01423772 | |
| 655 | 7 | |a Conference papers and proceedings. |2 lcgft | |
| 655 | 7 | |a Actes de congr�es. |2 rvmgf |0 (CaQQLa)RVMGF-000001049 | |
| 700 | 1 | |a Auriche, Michel, |e editor. | |
| 700 | 1 | |a Burke, John McDonald, |e editor. | |
| 700 | 1 | |a Duchier, Jacques, |e editor. | |
| 776 | 0 | 8 | |i Print version: |a International Congress of Pharmaceutical Physicians (4th : 1981 : Paris, France). |t Drug safety |z 0080270743 |w (OCoLC)10444955 |
| 856 | 4 | 0 | |u https://sciencedirect.uam.elogim.com/science/book/9780080270746 |z Texto completo |